|
Therapeutic response to Co-artesiane® |
||||
| Variable |
Chongwe N = 54 |
Chipata N = 57 |
||
|
|
||||
| n |
% |
n |
% |
|
|
|
||||
| Exclusion |
0 |
0 |
1 |
1.8 |
| Loss to follow-up |
0 |
0 |
6 |
10.5 |
| Withdrawal |
0 |
0 |
2 |
3.5 |
| ETFU |
0 |
0 |
0 |
0 |
| LCFU |
8 |
14.8 |
8 |
14 |
| LPFU |
19 |
35.2 |
6 |
10.5 |
| ACPRU |
27 |
50 |
39 |
68.4 |
| Re-infections |
20 |
37 |
10 |
17.5 |
| LTFC |
0 |
0 |
0 |
0 |
| Inadequate sample |
7 |
3 |
||
| Evaluable |
47 |
44 |
||
| ACPRC |
47 |
100 |
44 |
100 |
Chanda et al. Malaria Journal 2006 5:75 doi:10.1186/1475-2875-5-75 |
||||